![]() ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. | Nanobiosym Nanobiosym (NBS) is a company that focuses on the commercialization of its proprietary technology platform, that can detect genetic fingerprints from biological organisms, providing people with diagnostic information about their health. | 20Med Therapeutics 20Med Therapeutics is a biotechnology company applying nanotechnology for the development of RNA therapeutics. | |||
Founding Date | Founding Date 2018 | Founding Date 2015 | Founding Date 2004 | Founding Date 2011 | Founding Date 2016 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Woburn, US HQ | Locations Menlo Park, US HQ | Locations Cambridge, US HQ | Locations Leiden, NL HQ Enschede, NL | Locations Złotniki, PL HQ |
Employees | Employees 433% increase | Employees 1062% decrease | Employees 9 | Employees 11 | Employees 156% decrease |

ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
View companyNanobiosym (NBS) is a company that focuses on the commercialization of its proprietary technology platform, that can detect genetic fingerprints from biological organisms, providing people with diagnostic information about their health.
View company20Med Therapeutics is a biotechnology company applying nanotechnology for the development of RNA therapeutics.
View companygenXone is a company specializing in molecular genetics.
View company